Citations

Clear

350 citation(s) found for "Stevens, V".

Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer
Stevens, Kristen N., Vachon, Celine M. , Slager, Susan, Lesnick, Timothy G. , Olswold, Curtis, Fasching, Peter A. , Miron, Penelope , Eccles, Diana , Carpenter, Jane, Winqvist, Robert , Brauch, Hiltrud , Schmidt, Marjanka K. , Cox, Angela , Cross, Simon S. , Sawyer, Elinor J. , Hartmann, Arndt, Beckmann, Matthias W. , Schulz-Wendtland, Rüdiger, Ekici, Arif B. , Tapper, William , Gerty, Susan M. , Durcan, Lorraine , Graham, Nikki , Hein, Rebecca, Nickels, Stephan, Flesch‐Janys, Dieter, Heinz, Judith , Sinn, Hans‐Peter , Konstantopoulou, Irene , Pectasides, Dimitrios , Dimopoulos, Athanasios M., Clarke, Christine L. , Balleine, Rosemary L. , Fredericksen, Zachary, Diasio, Robert B. , Ross, Eric A. , Weaver, JoEllen , Rüdiger, Thomas , Dünnebier, Thomas, Ademuyiwa, Foluso O. , Kulkarni, Swati , Pylkäs, Katri , Jukkola‐Vuorinen, Arja , Ko, Yon‐Dschun, Limbergen, Erik Van, Janssen, Hilde, Peto, Julian , Fletcher, Olivia , Giles, Graham G. , Baglietto, Laura , Verhoef, Senno, Tomlinson, Ian , Kosma, Veli‐Matti , Greco, Dario , Blomqvist, Carl , Irwanto, Astrid , Liu, Jianjun , Blows, Fiona M., Dawson, Sarah‐Jane , Margolin, Sara , Mannermaa, Arto, Martin, Nicholas G. , Montgomery, Grant W. , Lambrechts, Diether , dos‐Santos‐Silva, Isabel , Severi, Gianluca , Hamann, Ute, Easton, Douglas F., Chang‐Claude, Jenny , Yannoukakos, Drakoulis , Nevanlinna, Heli , Dimopoulos, Meletios Α. , Purrington, Kristen S. , Lambrechts, Diether , Vachon, Celine M. , Lee, Adam M. , Godwin, Andrew K. , Ambrosone, Christine B. , Fostira, Florentia , Dimopoulos, Athanasios M., Fountzilas, George , Olson, Janet E. , Pathak, Harsh B. , Försti, Asta , Beesley, Jonathan , Mannermaa, Arto, Pharoah, Paul D.P. , Wang, Xianshu , Couch, Fergus J. , Nevanlinna, H , Lambrechts, Diether , Giles, Graham G , Eccles, Diana , Dimopoulos, Meletios A , Konstantopoulou, Irene , Martin, Nicholas G , Sinn, Peter , Lambrechts, Diether , Cox, Angela , Schmidt, Marjanka K , Severi, Gianluca , Ekici, Arif B , Ademuyiwa, Foluso O , Pylkäs, Katri , Yannoukakos, Drakoulis , Baglietto, Laura , Fletcher, Olivia , Purrington, Kristen S , Brauch, Hiltrud , Sawyer, Elinor J , Liu, Jing

Mayo Clinic

Cancer Research | August 15, 2011 | Volume: 71 | Issue: 19 | Pages: 6240-6249

10.1158/0008-5472.can-11-1266 | PMID 21844186 Get It

Abstract Triple-negative breast cancers are an aggressive subtype of breast cancer with poor survival, but there remains little known about the etiologic factors that promote its initiation and development. Commonly inherited breast cancer risk factors identified through genome-wide association studies display heterogeneity of effect among breast cancer subtypes as defined by the status of estrogen and progesterone receptors. In the Triple Negative Breast Cancer Consortium (TNBCC), 22 common breast cancer susceptibility variants were investigated in 2,980 Caucasian women with triple-negative breast cancer and 4,978 healthy controls. We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer. Together, our results provide convincing evidence of genetic susceptibility for triple-negative breast cancer. Cancer Res; 71(19); 6240–9. ©2011 AACR.
Time Course of Release in vivo of PGE 2 , PGF 2α , 6-Keto-PGF 1α , and TxB 2
Stevens, Mark K., Yaksh, Tony L.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | April 8, 2011 | Volume: 8 | Issue: 6 | Pages: 790-798

10.1038/jcbfm.1988.134 | PMID 3142890 Get It

The time-dependent release of prostaglandin E 2 (PGE 2 ), prostaglandin F 2α (PGF 2α ), thromboxane (Tx) B 2 , and 6-keto-PGF 1α (6-keto) from brain was measured before, during, and after a 15-min interval of total ischemia (four-vessel occlusion) in halothane-anesthetized cats using the technique of cerebroventricular perfusion. Resting levels of PGE 2 , PGF 2α , 6-keto, and Tx were: 253 ± 75, 953 ± 300, 650 ± 200, and 550 ± 170 pg/ml, respectively. During the 15-min ischemia, all prostanoids rose significantly, yet the highest levels were not observed until the first 15–60 min of the reflow at which time levels of PGE 2 , PGF 2α , 6-keto, and Tx, as compared with the preischemic baseline, rose ∼8, 3.4, 3, and 55-fold, respectively. Significantly, although all prostanoids showed increases relative to baseline, the ratios of PGF 2α /6-keto and PGE 2 /6-keto remained stable throughout the experiment in both groups of animals. In contrast, the Tx/6-keto ratio rose from ∼1 to ∼ 30 during the 60 min after reflow in untreated cats. Treatment with zomepirac sodium (5 mg/kg, i.v.), a cyclooxygenase inhibitor, resulted in highly significant reductions in the levels of all prostanoids during the preischemic period. In zomepirac sodium-treated animals, there were also highly significant reductions in the prostanoid response to ischemia. Of particular interest was that the degree of inhibition of Tx as compared with 6-keto, during the post-ischemic period of peak secretion was such that the Tx/6-keto ratio fell from 30 in the control ischemic animal to 0.3 in the zomepirac sodium-treated animal, suggesting a selective blockade of the formation of Tx as compared with prostacyclin.
Effect of Preischemia Cyclooxygenase Inhibition by Zomepirac Sodium on Reflow, Cerebral Autoregulation, and EEG Recovery in the Cat after Global Ischemia
Stevens, Mark K., Yaksh, Tony L. , Hansen, Robert B., Anderson, Robert E.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | April 8, 2011 | Volume: 6 | Issue: 6 | Pages: 691-702

10.1038/jcbfm.1986.125 | PMID 3098746 Get It

Zomepirac sodium (ZS) (5 mg/kg i.v.) was used to evaluate the effects of preischemia cyclooxygenase inhibition on CBF (as assessed by 133 Xe clearance), CBF–P a CO 2 responsiveness, and electrophysiologic (EEG) parameters before and after a 15-min period of complete global ischemia produced by four-vessel occlusion and mild hypotension. During the 15-min period of ischemia, CBF was essentially zero. Following reflow all groups displayed an initial hyperemia as compared with control (92 ± 11 vs. 141–146 ml/100 g/min). Saline-treated animals during reflow displayed a delayed hypoperfusion (26 ± 3 ml/100 g/min), which showed no improvement during the 2-h reflow period prior to death. In contrast, ZS-treated animals during reflow displayed significantly higher flows during the hypoperfusion phase (72 ± 9 ml/100 g/min). The CBF–P a CO 2 response displayed an approximately sevenfold reduction in slope at 2 h after reflow in saline-treated animals. This decrease in P a CO 2 reactivity was not observed in the ZS-pretreated animals. With regard to EEG, all animals showed a total flattening during the 15 min of ischemia. In saline-treated animals only one of seven showed any sign of even marginal recovery. In ZS-treated animals EEG activity showed prominent recovery in seven of seven. Brainstem auditory evoked potentials were monitored and showed prominent recovery of amplitude and latency in ZS but not saline-treated animals during reflow.
Systematic Studies on the Effects of the NMDA Receptor Antagonist MK-801 on Cerebral Blood Flow and Responsivity, EEG, and Blood-Brain Barrier following Complete Reversible Cerebral Ischemia
Stevens, Mark K., Yaksh, Tony L.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | April 8, 2011 | Volume: 10 | Issue: 1 | Pages: 77-88

10.1038/jcbfm.1990.10 | PMID 2153692 Get It

The dose-dependent effects of MK-801, a glutamate receptor antagonist, on changes in CBF, CBF-P a co 2 responsiveness ( 133 Xe clearance), EEG, and blood-brain barrier (methylene blue) were examined after a 15-min period of reversible complete global ischemia induced in halothane-anesthetized cats by occlusion of the vertebral and carotid arteries. Pretreatment with doses of MK-801 of ≥0.5 mg/kg had no effect on resting CBF measures and produced a dose-dependent slowing of the dominant EEG frequency. In animals receiving this agent, there was an almost immediate return of baseline EEG patterns upon reinstitution of flow, no hypoperfusion after 2 h of reflow, preservation of CBF and CBF-P a co 2 responsiveness, and maintenance of blood-brain barrier integrity. In contrast, parallel control animals and animals treated with MK-801 at a dose of 0.1 mg/kg exhibited poor recovery based on the above parameters. MK-801 also diminished in a dose-dependent manner the CSF levels of 6-keto-prostaglandin (PG) F 1α (stable metabolite of PGI 2 ) and thromboxane (Tx) B 2 (stable metabolite of TxA 2 ), which were otherwise elevated in vehicle-treated animals 2 h after reflow. Of particular interest, the CSF TxB 2 /6-keto-PGF 1α ratio in vehicle-treated animals was near 2. In animals pretreated with MK-801, at doses of ≥0.5 mg/kg, this ratio was nearly 1. These observations are consistent with a possible triggering role of glutamate release in initiating at least part of the acute sequelae of ischemia. Such release in an electrically silent cell would increase C a 2+ influx and activate free fatty acid metabolism, leading to probable changes in vascular function and changes in blood-brain barrier permeability.
Strategic Plan for Lung Vascular Research: An NHLBI-ORDR Workshop Report
Erzurum, Serpil C. , Rounds, Sharon , Stevens, Troy , Aldred, Micheala A. , Aliotta, Jason M., Asosingh, Kewal, Balaban, Robert S. , Bauer, Natalie , Bhattacharya, Jahar , Bogaard, Harm Jan , Choudhary, Gaurav , Dorn, Gerald W., Dweik, Raed A. , Fagan, Karen, Fallon, Michael B. , Finkel, Toren , Geraci, Mark W. , Gladwin, Mark T. , Humbert, Marc , Kaminski, Naftali , McMurtry, Ivan F., Newman, John H. , Nicolls, Mark R. , Rabinovitch, Marlene , Shizuru, Judy, Oka, Masahiko, Polgàr, Péter , Rodman, David M., Schumacker, Paul T. , Stenmark, Kurt R. , Tuder, Rubin M. , Voelkel, Norbert F., Sullivan, Eugene J., Weinshilboum, Richard M. , Yöder, Mervin C. , Zhao, Yingming , Gail, Dorothy B., Moore, Timothy M. , Archer, Stephen L. , Hassoun, Paul M. , Kawut, Steven M. , Loscalzo, Joseph , McDonald, Donald M. , Weinshilboum, Richard M. , Kaminski, Naftali

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | September 10, 2010 | Volume: 182 | Issue: 12 | Pages: 1554-1562

10.1164/rccm.201006-0869ws | PMID 20833821 Get It

Abstract The Division of Lung Diseases of the National Heart, Lung, and Blood Institute, with the Office of Rare Diseases Research, held a workshop to identify priority areas and strategic goals to enhance and accelerate research that will result in improved understanding of the lung vasculature, translational research needs, and ultimately the care of patients with pulmonary vascular diseases. Multidisciplinary experts with diverse experience in laboratory, translational, and clinical studies identified seven priority areas and discussed limitations in our current knowledge, technologies, and approaches. The focus for future research efforts include the following: (1) better characterizing vascular genotype–phenotype relationships and incorporating systems biology approaches when appropriate; (2) advancing our understanding of pulmonary vascular metabolic regulatory signaling in health and disease; (3) expanding our knowledge of the biologic relationships between the lung circulation and circulating elements, systemic vascular function, and right heart function and disease; (4) improving translational research for identifying disease-modifying therapies for the pulmonary hypertensive diseases; (5) establishing an appropriate and effective platform for advancing translational findings into clinical studies testing; and (6) developing the specific technologies and tools that will be enabling for these goals, such as question-guided imaging techniques and lung vascular investigator training programs. Recommendations from this workshop will be used within the Lung Vascular Biology and Disease Extramural Research Program for planning and strategic implementation purposes.
Unnecessary Child Care Exclusions in a State That Endorses National Exclusion Guidelines
Hashikawa, Andrew N. , Juhn, Young J. , Nimmer, Mark, Copeland, Kristen A. , Li, Shun-Hwa, Simpson, Pippa , Stevens, Martha W., Brousseau, David C.

Mayo Clinic

Pediatrics | April 20, 2010 | Volume: 125 | Issue: 5 | Pages: 1003-1009

10.1542/peds.2009-2283 | PMID 20403929 Get It

OBJECTIVE:No study has evaluated the association between state endorsement of American Academy of Pediatrics (AAP) and American Public Health Association (APHA) national guidelines and unnecessary exclusion decisions. We sought to determine the rate of unnecessary exclusion decisions by child care directors in a state that endorses AAP/APHA guidelines and to identify factors that are associated with higher unnecessary exclusion decisions.METHODS:A telephone survey was administered to directors in metropolitan Milwaukee, Wisconsin. Directors were randomly sampled from a list of 971 registered centers. Director, center, and neighborhood characteristics were obtained. Directors reported whether immediate exclusion was indicated for 5 vignettes that featured children with mild illness that do not require exclusion by AAP/APHA guidelines. Weighted data were summarized by using descriptive statistics. Regression analysis was used to identify factors that were associated with directors' exclusion decisions.RESULTS:A total of 305 directors completed the survey. Overall, directors would unnecessarily exclude 57% of children. More than 62% had never heard of the AAP/APHA guidelines. Regression analysis showed fewer exclusions among more experienced compared with less experienced directors, among larger centers compared with smaller centers, and among centers that were located in areas with a higher percentage of female heads of household. Centers with ≤10% children on state-assisted tuition excluded more.CONCLUSIONS:High rates of inappropriate exclusion persist despite state endorsement of AAP/APHA guidelines. Focused initial and ongoing training of directors regarding AAP/APHA guidelines may help to reduce high rates of unnecessary exclusions.
Dose to Radiosensitive Organs During Routine Chest CT: Effects of Tube Current Modulation
Angel, Erin , Yaghmai, Nazanin, Jude, Cecilia M., DeMarco, John J., Cagnon, Christopher H., Goldin, Jonathan , Primak, Andrew N. , Cody, Dianna D. , Stevens, Donna M., Cagnon, Chris H., McCollough, Cynthia H. , McNitt‐Gray, Michael F.

Mayo Clinic

American Journal of Roentgenology | October 20, 2009 | Volume: 193 | Issue: 5 | Pages: 1340-1345

10.2214/ajr.09.2886 | PMID 19843751 Get It

Spirituality during Alcoholism Treatment and Continuous Abstinence for One Year
Piderman, Katherine M. , Schneekloth, Terry D. , Pankratz, V. Shane , Stevens, Susanna R., Altchuler, Steven I.

Mayo Clinic

The International Journal of Psychiatry in Medicine | April 6, 2009 | Volume: 38 | Issue: 4 | Pages: 391-406

10.2190/pm.38.4.a | PMID 19480354 Get It

Objective: The primary aim of this prospective study was to examine the role of several aspects of spirituality in maintaining abstinence from alcohol for one year in persons treated for alcohol dependence. The roles of alcohol abstinence self-efficacy and Alcoholics Anonymous affiliation were also examined. Method: Seventy-four adults with alcohol dependence who had completed a three-week outpatient addiction program participated in this study. Instruments used included the Spiritual Well-Being Scale, Duke Religion Index, Brief Religious Coping Scale, Alcohol Abstinence Self-Efficacy Scale, and Alcoholics Anonymous Affiliation Scale. Abstinence data was collected from participants and collaterals three, six, and twelve months after treatment discharge. Demographics, discharge measures, and the change in scores from admission to discharge were compared between those with and without 12-month alcohol abstinence using logistic regression or Fisher's exact tests. Results: Twenty-eight participants were categorized as continuously abstinent for one year. The strongest associations between 12 month abstinence and the variables of interest were discharge scores of abstinence self-efficacy and existential well-being, and increases during treatment in scores of private spiritual practices. Increased age demonstrated a significant association with positive outcome. Conclusion: The associations of private spiritual practices, existential well-being, and abstinence self-efficacy with one year of continuous abstinence following treatment discharge suggest the importance of addressing issues related to these variables during alcoholism treatment. More research is needed to understand the role of these variables in promoting and maintaining abstinence and to determine whether or not a related intervention would improve abstinence rates.
Long-term trends in carpal tunnel syndrome
Gelfman, Russell , Melton, L. Joseph, Yawn, Barbara P. , Wollan, Peter C. , Amadio, Peter C. , Stevens, J. Clarke

Mayo Clinic

Neurology | January 2, 2009 | Volume: 72 | Issue: 1 | Pages: 33-41

10.1212/01.wnl.0000338533.88960.b9 | PMID 19122028 Get It

Change in Perceived Stress, Partner Support, Decisional Balance, and Self-Efficacy Following Residential Nicotine Dependence Treatment
Ames, Steven C. , Croghan, Ivana T. , Clark, Matthew M. , Stevens, Susanna R., Schroeder, Darrell R. , Eberman, Kay M., Hurt, R. Douglas , Patten, Christi A. , Hays, J. Taylor , Schroeder, Darrell

Mayo Clinic

Journal of Addictive Diseases | December 30, 2008 | Volume: 27 | Issue: 1 | Pages: 73-82

10.1300/j069v27n01_08 | PMID 18551890 Get It